OBES SURG (2017) 27:3306–3313 DOI 10.1007/s11695-017-2939-4 NEW CONCEPT Safety and Effectiveness of an Endoscopically Placed Duodenal-Jejunal Bypass Device (EndoBarrier®): Outcomes in 114 Patients 1 2,3 1 2,3 Patrice M. Forner & Timothy Ramacciotti & John E. Farey & Reginald V. Lord Published online: 11 October 2017 Springer Science+Business Media, LLC 2017 Abstract acute pancreatitis. Seventy-four percent of patients experi- Background The duodenal-jejunal bypass liner (DJBL) is an enced weight gain after removal with a mean 4.5 ± 6.1 kg endoscopically placed device designed to achieve weight loss (p < 0.0001) within the first 6 months after explantation. and improve glycemic control in obese patients. Previous Conclusions The DJBL provides significant but highly vari- studies report promising results but typically included small able weight loss. Glycemic control was variable. Most insulin- patient numbers and short follow-up. This study aims to de- requiring T2DM patients ceased or reduced insulin. Most pa- termine the safety and effectiveness of the device. tients experience an adverse event and most regain significant Methods Study design: weight after device removal. Major adverse events can occur, A series of all patients treated by the DJBL at our including the potentially life-threatening complications of he- institutions. patic abscess
Obesity Surgery – Springer Journals
Published: Oct 11, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera